tiprankstipranks
Trending News
More News >
Xspray Pharma AB (SE:XSPRAY)
:XSPRAY
Sweden Market

Xspray Pharma AB (XSPRAY) Income Statement

Compare
0 Followers

Xspray Pharma AB Income Statement

Last quarter (Q4 2024), Xspray Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Xspray Pharma AB's net income was kr-81.97M. See Xspray Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -9.19Mkr -9.53Mkr -8.87Mkr -1.41Mkr -4.80M
Operating Expenses
kr 181.73Mkr 131.38Mkr 96.95Mkr 53.65Mkr 45.76M
Depreciation and Amortization
kr 9.19Mkr 9.53Mkr 8.87Mkr 1.41Mkr 4.80M
EBITDA
kr -169.81Mkr -122.13Mkr -87.82Mkr -50.99Mkr -40.90M
Operating Income
kr -180.76Mkr -133.07Mkr -97.95Mkr -53.46Mkr -45.70M
Other Income/Expenses
kr 1.08Mkr 1.40Mkr 1.25Mkr 1.05Mkr -15.00K
Pretax Income
kr -179.68Mkr -131.67Mkr -96.70Mkr -52.41Mkr -45.77M
Net Income
kr -179.67Mkr -130.27Mkr -96.70Mkr -52.30Mkr -45.84M
Per Share Metrics
Basic EPS
kr -6.76kr -6.13kr -4.98kr -3.01kr -2.99
Diluted EPS
kr -6.76kr -6.13kr -4.98kr -3.01kr -2.99
Weighted Average Shares Outstanding
26.58M 21.26M 19.41M 17.37M 15.35M
Weighted Average Shares Outstanding (Diluted)
26.59M 21.26M 19.41M 17.37M 15.35M
Currency in SEK

Xspray Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis